Kory Wentworth
Directeur Financier/CFO chez ENTRADA THERAPEUTICS, INC.
Fortune : 219 884 $ au 30/04/2024
Postes actifs de Kory Wentworth
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2020 | - |
| Treasurer | 01/11/2020 | - |
Historique de carrière de Kory Wentworth
Anciens postes connus de Kory Wentworth
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18/12/2017 | 08/09/2020 |
| Treasurer | 18/12/2017 | 02/10/2020 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/11/2017 | 01/12/2017 |
| Directeur/Membre du Conseil | 01/01/2012 | 01/12/2017 | |
| Corporate Officer/Principal | 01/12/2008 | 01/12/2017 |
Formation de Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Kory Wentworth
- Expérience